GlycoMar is developing two consumer healthcare products: this first for the menagement of eczema (atopic dermatitis) and the second for the managment of rhinitis (hay fever). These products will provide effective natural treatments of inflammatory and allergic conditions where treatment is currently dominated by steroids.
GlycoMar is using its expertise in glycobiology and inflammation for the development of two new products. These products are being built on active glycomoecules that Glycomar has characaterised over 10 years of research & development. The active ingrediients are sustainably sourced and fully natural, and are being developed to give an excellent efficacy and safety profile. Full details of these products will be provided in due course.